Lia Monsalve Arteaga1, Juan Luis Muñoz Bellido2, Ana Isabel Negredo3, Jorge García Criado4, Maria Carmen Vieira Lista1, Jesús Ángel Sánchez Serrano4, María Belén Vicente Santiago1, Amparo López Bernús1,5, Fernando de Ory Manchón6, María Paz Sánchez Seco3, Nuria Leralta6, Montserrat Alonso Sardón1, Antonio Muro1, Moncef Belhassen-García1,5. 1. Infectious and Tropical Diseases Group (e-INTRO), IBSAL-CIETUS (Biomedical Research Institute of Salamanca-Research Center for Tropical Diseases at the University of Salamanca), Faculty of Pharmacy, University of Salamanca, Salamanca, Spain. 2. Servicio de Microbiología y Parasitología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain. 3. Arbovirus and Imported Viral Diseases Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Red de Investigación Colaborativa en Enfermedades Tropicales, Madrid, Spain. 4. Emergency Department, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain. 5. Internal Medicine and Infectious Disease Department, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain. 6. Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, España; Ciber en Salud Pública (CIBERESP), Instituto de Salud Carlos III, Spain.
Abstract
BACKGROUND: Crimean-Congo haemorrhagic fever (CCHF) is a widespread tick-borne viral disease caused by the Crimean-Congo haemorrhagic fever virus (CCHFV). CCHFV has been implicated in severe viral haemorrhagic fever outbreaks. During the summer of 2016, the first two cases with genotype III (Africa 3) were reported in Spain. The first objective of our study was to determine the presence of CCHFV among patients with febrile illness during the spring and summer periods in 2017 and 2018. Finally, we perform a phylogenetic analysis to determine the genotype of the virus. METHODOLOGY: We prospectively evaluated patients aged 18 years and older who came to the emergency department at the Salamanca's University Hospital (HUS) with fever. Specific IgM and IgG antibodies against CCHFV by ELISA and one immunofluorescence assay against two different proteins (nucleoprotein and glycoprotein C) was done. Moreover, molecular detection by Real Time PCR was performed in all collected samples. A phylogenetic analysis was carried out to genetically characterize CCHFV detected in this study. PRINCIPAL FINDINGS: A total of 133 patients were selected. The mean age was 67.63 years and 60.9% were male. One-third of the patients presented an acute undifferentiated febrile illness. Three patients had anti-CCHFV IgG antibodies, suggesting a previous infection. One patient had anti-CCHFV IgM antibodies and a confirmatory RT-PCR. Phylogenetic analysis indicated that the virus corresponds to the European genotype V. This patient came to the emergency department at HUS in August 2018 presenting an acute febrile syndrome with thrombopenia and liver impairment. CONCLUSIONS: We describe a new circulation of European genotype V CCHFV in Spain. Moreover, this study suggests that CCHFV is an identifiable cause of febrile illness of unknown origin in Spain. Thus, CCHF could be suspected in patients with fever, liver damage, and/or haemorrhagic disorders, particularly in people with risk activities who present in the spring or summer.
BACKGROUND:Crimean-Congo haemorrhagic fever (CCHF) is a widespread tick-borne viral disease caused by the Crimean-Congo haemorrhagic fever virus (CCHFV). CCHFV has been implicated in severe viral haemorrhagic fever outbreaks. During the summer of 2016, the first two cases with genotype III (Africa 3) were reported in Spain. The first objective of our study was to determine the presence of CCHFV among patients with febrile illness during the spring and summer periods in 2017 and 2018. Finally, we perform a phylogenetic analysis to determine the genotype of the virus. METHODOLOGY: We prospectively evaluated patients aged 18 years and older who came to the emergency department at the Salamanca's University Hospital (HUS) with fever. Specific IgM and IgG antibodies against CCHFV by ELISA and one immunofluorescence assay against two different proteins (nucleoprotein and glycoprotein C) was done. Moreover, molecular detection by Real Time PCR was performed in all collected samples. A phylogenetic analysis was carried out to genetically characterize CCHFV detected in this study. PRINCIPAL FINDINGS: A total of 133 patients were selected. The mean age was 67.63 years and 60.9% were male. One-third of the patients presented an acute undifferentiated febrile illness. Three patients had anti-CCHFV IgG antibodies, suggesting a previous infection. One patient had anti-CCHFV IgM antibodies and a confirmatory RT-PCR. Phylogenetic analysis indicated that the virus corresponds to the European genotype V. This patient came to the emergency department at HUS in August 2018 presenting an acute febrile syndrome with thrombopenia and liver impairment. CONCLUSIONS: We describe a new circulation of European genotype V CCHFV in Spain. Moreover, this study suggests that CCHFV is an identifiable cause of febrile illness of unknown origin in Spain. Thus, CCHF could be suspected in patients with fever, liver damage, and/or haemorrhagic disorders, particularly in people with risk activities who present in the spring or summer.
Authors: Anabel Negredo; Fernando de la Calle-Prieto; Eduardo Palencia-Herrejón; Marta Mora-Rillo; Jenaro Astray-Mochales; María P Sánchez-Seco; Esther Bermejo Lopez; Javier Menárguez; Ana Fernández-Cruz; Beatriz Sánchez-Artola; Elena Keough-Delgado; Eva Ramírez de Arellano; Fátima Lasala; Jakob Milla; Jose L Fraile; Maria Ordobás Gavín; Amalia Martinez de la Gándara; Lorenzo López Perez; Domingo Diaz-Diaz; M Aurora López-García; Pilar Delgado-Jimenez; Alejandro Martín-Quirós; Elena Trigo; Juan C Figueira; Jesús Manzanares; Elena Rodriguez-Baena; Luis Garcia-Comas; Olaia Rodríguez-Fraga; Nicolás García-Arenzana; Maria V Fernández-Díaz; Victor M Cornejo; Petra Emmerich; Jonas Schmidt-Chanasit; Jose R Arribas Journal: N Engl J Med Date: 2017-07-13 Impact factor: 91.245
Authors: Barry Atkinson; John Chamberlain; Christopher H Logue; Nicola Cook; Christine Bruce; Stuart D Dowall; Roger Hewson Journal: Vector Borne Zoonotic Dis Date: 2012-01-04 Impact factor: 2.133
Authors: María Carmen Vieira Lista; Moncef Belhassen-García; María Belén Vicente Santiago; Javier Sánchez-Montejo; Carlos Pedroza Pérez; Lía Carolina Monsalve Arteaga; Zaida Herrador; Rufino Del Álamo-Sanz; Agustin Benito; Julio David Soto López; Antonio Muro Journal: Insects Date: 2022-05-18 Impact factor: 3.139
Authors: María Paz Sánchez-Seco; María José Sierra; Agustín Estrada-Peña; Félix Valcárcel; Ricardo Molina; Eva Ramírez de Arellano; Angeles Sonia Olmeda; Lucía García San Miguel; Maribel Jiménez; Luis J Romero; Anabel Negredo Journal: Emerg Infect Dis Date: 2021-02 Impact factor: 6.883